About Raquel

Ms. Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), an international umbrella organisation of more than 250 hepatitis groups which she helped to establish in 2007 because viral hepatitis had been inexplicably neglected for so long. This persistent neglect means that there is an awful lot of catching up to do so she campaigns for a higher profile and priority for these diseases, ensuring the voices of patients are at the forefront of national and global health discussions.

Before being appointed CEO, Raquel worked as the International Relations Director for the WHA and was part seconded to the World Health Organization (WHO) after the Global Hepatitis Programme was established to help the team in Geneva with their communications strategy. Previously to this she was employed as a Public Relations Coordinator for the only UK national charity dedicated to hepatitis C - The Hepatitis C Trust. Raquel’s work in the field was instrumental to the adoption of three WHO resolutions on hepatitis, the third resulting in the ratification of a robust Elimination Strategy for the disease by 194 governments in 2016. She is committed to seeing a world where viral hepatitis is no longer a public health issue and will continue to campaign for the ultimate goal of eliminating the epidemic.

This speaker will be presenting at the following session(s)

  • Making elimination a reality

    Golden Hall

    Day: 1 November

    Time: 10:30

    This session will bring together a group of visionaries from all walks of life who champion the cause of elimination to participate in a dialogue around achieving the common goal of elimination.

    Presentations:

    • Making elimination a reality: overview.

      Speaker: Dr. Gottfried Hirnschall, World Health Organization

    • NOhep Visionaries.

      Speakers: Raquel Peck, World Hepatitis Alliance

    • High level panel.
    1. Participating governments
    2. International partners
  • Strategic direction 1: strategic information for focused action

    Golden Hall

    Day: 1 November

    Time: 13:30

    The Summit’s agenda takes the Global Health Sector Strategy on Viral Hepatitis (GHSS) - and its 5 strategic directions - as its framework. In this plenary session, strategic direction 1 looks at advocacy, political commitment and national planning.

    Chairs: Dr. Leolin Katsidzira, University of Zimbabwe College of Health Sciences and Tatjana Reic, European Liver Patients’ Association

    Presentations:

    • Global viral hepatitis situation and response.

      Dr. Marc Bulterys, World Health Organization

    • WHO country profiles report.

      Prof. Sharon Hutchinson, Glasgow Caledonian University, UK

    • The power of people: integrating civil society in the global hepatitis response.

      Raquel Peck, World Hepatitis Alliance

    • The role of liver societies in the global viral hepatitis response.

      Anna Lok, American Association for the Study of Liver Diseases

    • Country level experience of using strategic information to inform their national hepatitis response. 
      Myanmar - Patient registries and serosurveys
      Zimbabwe - Rapid assessments: Dr. Leolin Katsidzira, University of Zimbabwe College of Health Sciences
      Vietnam - Sentinel surveillance
      Brazil – Scaling-up treatment services: Dr. Adele Benzaken, Ministry of Health, Brazil
    • Q&A session.

    Session objectives:

    To highlight

    • The role and importance of strategic information in planning and monitoring national responses.

    • The priority actions for countries and role of WHO in supporting countries.

    • The latest data on the global viral hepatitis situation and response.

    • Progress made in integrating civil society in the global viral hepatitis response and on global awareness activities.

    • Country examples demonstrating the important role of strategic information for focused action.